ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 526

Citrullinated Fibrinogen Promotes Bone Marrow Mesenchymal Stem Cells to Assume a Proinflammatory Phenotype

Yue Sun, Wei Deng, Weiwei Chen, Genhong Yao, Xuebing Feng and Lingyun Sun, Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: mesenchymal stem cells and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Mesenchymal stem cells (MSC) are not only immune-inhibitory cells, and may act as pro-inflammatory cells due to lack of a proper “licensing”. The role of MSC in autoimmune settings of rheumatoid arthritis (RA) has remained to be elucidated. Citrullinated fibrinogen (cfb) has been considered as one of the important autoantigens in RA and contributes to perpetuate the disease. Our study aimed to analyze the responses of bone marrow derived MSC (BMSC) to cfb.

Methods: BMSC were isolated from RA and osteoarthritis (OA) patients and exposed to cfb or native fibrinogen (fb). Proinflammatory cytokines stimulated by cfb were determined by quantitative PCR and ELISA. To evaluate the role of the toll like receptor 4 (TLR4)-NFκB pathway in the induction of cytokines by cfb, parallel experiments were performed using inhibitors of TLR4 or NFκB pathway. To investigate whether BMSC retain their immunosuppressive properties after exposure to cfb, we detected the effects of cfb primed BMSC on proliferation of peripheral blood mononuclear cells (PBMC).

Results: The autoantigen cfb increased the gene expression and protein production of IL-6, IL-8 and CCL2 in BMSC from both RA and OA patients. However, the production of IL-1β and TNFα were unaffected by cfb. Compared with fb, cfb induced significantly higher expression of the pro-inflammatory cytokines (IL-6, IL-8 and CCL2) in these cells. Blocking experiments showed the participation of TLR4-NFκB pathway in the induction of these cytokines. The autoantigen cfb also compromised the ability of BMSC to inhibit PBMC proliferation, as well as, impaired the potency of BMSC to produce the key immunomodulatory molecule indoleamine dioxygenase (IDO).

Conclusion:  Our results suggest that cfb promotes pro-inflammatory responses in BMSC and negatively affects their immunomodulatory functions. Citrullinated fibrinogen may act as a dangerous “licensing” for BMSC and thereby contributing to the propagation of inflammation in RA.


Disclosure: Y. Sun, None; W. Deng, None; W. Chen, None; G. Yao, None; X. Feng, None; L. Sun, None.

To cite this abstract in AMA style:

Sun Y, Deng W, Chen W, Yao G, Feng X, Sun L. Citrullinated Fibrinogen Promotes Bone Marrow Mesenchymal Stem Cells to Assume a Proinflammatory Phenotype [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/citrullinated-fibrinogen-promotes-bone-marrow-mesenchymal-stem-cells-to-assume-a-proinflammatory-phenotype/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/citrullinated-fibrinogen-promotes-bone-marrow-mesenchymal-stem-cells-to-assume-a-proinflammatory-phenotype/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology